RYTMRhythm Pharmaceuticals, Inc.
Is it growing?
Growing: revenue growing +54% year on year and operating margin widening (+31.9 points).
Trailing-twelve-month revenue vs a year earlier, from the company's own filings.
Trailing-twelve-month operating margin, -85.0% now against -116.9% a year earlier.
All from SEC EDGAR, as of Jun 30, 2026.
Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.
Is RYTM growing?
Rhythm Pharmaceuticals, Inc. has grown revenue 100% a year over three years.
Revenue growth, 3-year annual rate · Biotechnology median +17% · compounding fast · compounded from fiscal-year columns as filed
- Years of annual history on file
- 11
Years of annual history on file · FY2015 to FY2025, as filed
Details›
- Revenue FY2021
- $3.2M
- Revenue FY2022
- $24M
- Revenue FY2023
- $77M
- Revenue FY2024
- $130M
- Revenue FY2025
- $190M
Annual income statements as filed with the SEC.